Hong Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy 68 (1) (2023)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy 68 (1) (2023)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy 68 (1) (2023)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy 68 (1) (2023)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy (2023)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy 68 (1) (2023)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy 68 (1) (2023)

Hong Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hong Zhang